Rola nauczyciela w zintegrowanym nauczaniu przedmiotowo-językowym (CLIL) na I etapie edukacji wczesnoszkolnej z perspektywy dzieci by Inga Maria Smoleń

Get full text

Cased hole and production log evaluation / by 367779 Smolen, Jim J.

Academic Researcher Work and the Confusion of Public Authorities. A Bleak Outlook for the Consequences of the Higher Education Reform in Poland – Comparative Approach by M. Świstak, P. Smoleń

Get full text

ECG biometric recognition in different physiological conditions using robust normalized QRS complexes by Sidek, Khairul Azami, Khalil, Ibrahim, Smolen, Magdalena

Get full text

ECG biometric recognition in different physiological conditions using robust normalized QRS complexes by Sidek, Khairul Azami, Khalil, Ibrahim, Smolen, Magdalena

Get full text

Association between 5HTT, DAT1, and DRD4 and bipolar disorder in youth by Cosgrove, V, Miklowitz, D, Rhee, S, Hawkey, C, Corley, R, Haberstick, B, Smolen, A

Association between 5HTT, DAT1, and DRD4 and bipolar disorder in youth. by Cosgrove, V, Miklowitz, D, Rhee, S, Hawkey, C, Corley, R, Haberstick, B, Smolen, A

Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects by Bruno Fautrel, Josef S Smolen, Fabrizio Benedetti, Roberto Caporali, Thomas Doerner, Burkhard Pieper, Minjun Jang

Get full text

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis by Coates, L, Gossec, L, Ramiro, S, Mease, P, Van Der Heijde, D, Smolen, J, Ritchlin, C, Kavanaugh, A

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor in... by E. Feist, S. Fatenejad, S. Grishin, E. Korneva, M.E. Luggen, E. Nasonov, M. Samsonov, J.S. Smolen, R.M. Fleischmann

Get full text

Socio-Demographic Characteristics and Concerns about Water Quality Issues of Master Gardener Program Volunteers by Tatiana Borisova, Michael Smolen, Maria Pilar Useche, Jon Calabria, Nickola Sochacka, Damian Adams, Diane Boellstorff, Jason Evans, Robert Mahler

Get full text

Socio-Demographic Characteristics and Concerns about Water Quality Issues of Master Gardener Program Volunteers by Tatiana Borisova, Michael Smolen, Maria Pilar Useche, Jon Calabria, Nickola Sochacka, Damian Adams, Diane Boellstorff, Jason Evans, Robert Mahler

Get full text

Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated d... by Taylor, P, Takeuchi, T, Burmester, GR, Durez, P, Smolen, JS, Deberdt, W, Issa, M, Terres, JR, Bello, N, Winthrop, K

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. by Elliott, M, Maini, R, Feldmann, M, Kalden, JR, Antoni, C, Smolen, J, Leeb, B, Breedveld, F, Macfarlane, J, Bijl, H

Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors by Malm, E, Nielsen, SM, Berg, J, Ioannidis, JPA, Furst, DE, Smolen, JS, Taylor, PC, Kristensen, LE, Tarp, S, Ellingsen, T, Christensen, R

GOLIMUMAB IS EFFICACIOUS IN ANTI-TNF EXPERIENCED PTS WITH ACTIVE RA REGARDLESS OF TYPE OF AGENT OR REASON FOR DISCONTINUATION OF PRIOR ANTI-TNF: GO-AFTER STUDY by Smolen, J, Wordsworth, P, Doyle, M, Kay, J, Matteson, E, Landewe, R, Hsia, E, Zhou, Y, Rahman, M, Investigator, G

Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biologic or synthetic anti-rheumatic drugs:... by Berg, JI, Nielsen, SM, Malm, E, Ioannidis, JPA, Furst, DE, Smolen, JS, Taylor, PC, Kristensen, LE, Tarp, S, Ellingsen, T, Christensen, R

Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment by Eugen Feist, Roy M. Fleischmann, Saeed Fatenejad, Daria Bukhanova, Sergey Grishin, Sofia Kuzkina, Michael Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S. Smolen

Get full text

GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY) by Wordsworth, P, Smolen, J, Kay, J, Doyle, M, Landewe, R, Matteson, E, Zhou, Y, Hsia, E, Rahman, M, Investigators, GO-AFTERS

Comparing the patient reported physical function outcome measures in a real‐life international cohort of patients with psoriatic arthritis by Leung, YY, Orbai, AM, de Wit, M, Balanescu, A, Dernis, E, Soubrier, M, Eder, L, Smolen, JS, Coates, LC, Gossec, L